Federal Register of Legislation - Australian Government

Primary content

Criminal Code Regulations 2002

Authoritative Version
SR 2002 No. 67 Regulations as amended, taking into account amendments up to Criminal Code Amendment (High Risk Terrorist Offenders) Regulations 2017
Administered by: Attorney-General's; Home Affairs
Registered 20 Nov 2017
Start Date 18 Nov 2017

Commonwealth Coat of Arms of Australia

Criminal Code Regulations 2002

Statutory Rules No. 67, 2002

made under the

Criminal Code Act 1995

Compilation No. 54

Compilation date:                              18 November 2017

Includes amendments up to:            F2017L01490

Registered:                                         20 November 2017

 

About this compilation

This compilation

This is a compilation of the Criminal Code Regulations 2002 that shows the text of the law as amended and in force on 18 November 2017 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

  

  

  


Contents

Part 1—Preliminary                                                                                                                                        1

1............ Name of Regulations..................................................................................................... 1

3............ Definitions..................................................................................................................... 1

Part 2—Security of the Commonwealth                                                                                            3

Division 1—Control orders                                                                                                                 3

3A......... Legal representation for young people........................................................................... 3

3B......... Court may request legal aid commission to arrange representation................................ 3

3C......... AFP to inform relevant persons of request and contact details...................................... 3

Division 2—Preventative detention orders                                                                                 5

4............ Preventative detention orders—corresponding State preventative detention law........... 5

4A......... Continuing detention order proceedings—matters court may take into account in determining whether circumstances beyond offender’s control...................................................................... 5

4B......... Continuing detention orders—sharing information....................................................... 5

Part 3—Dangers to the community                                                                                                       7

Division 1—Cross‑border firearms trafficking                                                                        7

5............ Cross‑border firearms trafficking.................................................................................. 7

Division 2—Serious drugs and precursors                                                                                  8

5A......... Controlled drugs............................................................................................................ 8

5B......... Controlled plants........................................................................................................... 8

5C......... Controlled precursors.................................................................................................... 8

5D......... Border controlled drugs................................................................................................. 9

5E.......... Border controlled plants................................................................................................ 9

5F.......... Border controlled precursors....................................................................................... 10

Division 3—Psychoactive substances                                                                                           12

5G......... Importing psychoactive substances............................................................................. 12

5H......... Importing substances represented to be serious drug alternatives................................ 13

Part 4—National infrastructure                                                                                                            15

6............ Dangerous goods........................................................................................................ 15

Part 5—Application and transitional provisions                                                                         16

7............ Application of the Criminal Code Amendment (Control Orders—Legal Representation for Young People) Regulations 2017............................................................................................ 16

Schedule 1—Corresponding State preventative detention law              17

Part 1—Laws of a State or Territory                                                                                                 17

Part 2—Particular provisions of a law of a State or Territory                                          18

Schedule 2—Cross‑border firearms trafficking                                                     19

Schedule 3—Controlled drugs                                                                                                  20

Schedule 4—Border controlled drugs                                                                               28

Endnotes                                                                                                                                                               35

Endnote 1—About the endnotes                                                                                                      35

Endnote 2—Abbreviation key                                                                                                          36

Endnote 3—Legislation history                                                                                                       37

Endnote 4—Amendment history                                                                                                     41


Part 1Preliminary

  

1  Name of Regulations

                   These Regulations are the Criminal Code Regulations 2002.

3  Definitions

                   In these Regulations:

AFP member has the same meaning as in Part 5.3 of the Code.

authorised person means a person authorised in writing by the Health Secretary to be an authorised person for the purposes of regulation 5 of the Customs (Prohibited Imports) Regulations 1956.

chief executive officer of a legal aid commission of a State or Territory means the person holding, or performing the duties of, the following position:

                     (a)  for New South Wales, Queensland and the Australian Capital Territory—Chief Executive Officer of the legal aid commission of that State or Territory;

                     (b)  for Victoria—managing director of the board of directors of Victoria Legal Aid under the Legal Aid Act 1978 (Vic);

                     (c)  for Western Australia—Director of Legal Aid under the Legal Aid Commission Act 1976 (WA);

                     (d)  for South Australia—Director of Legal Services under the Legal Services Commission Act 1977 (SA);

                     (e)  for Tasmania—Director of the Commission under the Legal Aid Commission Act 1990 (Tas.);

                      (f)  for the Northern Territory—Director of Legal Aid under the Legal Aid Act (NT).

Code means the Criminal Code.

control order has the same meaning as in Part 5.3 of the Code.

Health Department means the Department administered by the Health Minister.

Health Minister means the Minister administering the Therapeutic Goods Act 1989.

Health Secretary means the Secretary to the Health Department.

issuing court has the same meaning as in Part 5.3 of the Code.

lawyer has the same meaning as in Part 5.3 of the Code.

legal aid commission means an authority established by or under a law of a State or Territory for the purpose of providing legal assistance.

mental impairment has a meaning affected by subsections 7.3(8) and (9) of the Code.

parent has a meaning affected by the Dictionary at the end of the Code.

Part 2Security of the Commonwealth

Division 1Control orders

3A  Legal representation for young people

                   For the purposes of subsection 104.28(6) of the Code, this Division provides in relation to the appointing of a lawyer for a person who is at least 14 but under 18 (the young person) to act for the young person in relation to proceedings relating to a control order.

3B  Court may request legal aid commission to arrange representation

                   An issuing court may request a legal aid commission (the relevant legal aid commission) to arrange the legal representation of the young person.

3C  AFP to inform relevant persons of request and contact details

             (1)  This regulation applies if the issuing court decides to make a request under regulation 3B.

Informing the legal aid commission

             (2)  An AFP member, or a legal representative of the Australian Federal Police, must:

                     (a)  in writing, inform the chief executive officer of the relevant legal aid commission of the request; and

                     (b)  give the relevant legal aid commission the following information (if any) that the AFP member or legal representative has:

                              (i)  the young person’s name;

                             (ii)  the young person’s residential address;

                            (iii)  the young person’s contact details, including a telephone number and an email address;

                            (iv)  the young person’s date of birth;

                             (v)  the name, residential address and contact details of at least one parent or guardian of the young person;

                            (vi)  if the young person requires assistance with communication—information about the assistance required.

Note:       For subparagraph (b)(vi), a person may need assistance with communication because, for example, the young person is deaf or hearing impaired, is unable to read, has a mental impairment, or requires an interpreter.

Informing the young person

             (3)  An AFP member must:

                     (a)  inform the young person of the request; and

                     (b)  give the young person sufficient information about the relevant legal aid commission to enable the young person to contact and, if necessary, attend the legal aid commission, including the following information (if any) that the AFP member has:

                              (i)  the name of the legal aid commission;

                             (ii)  the legal aid commission’s business address (not being a post box);

                            (iii)  the legal aid commission’s contact details, including a telephone number and an email address;

                            (iv)  any other information about the legal aid commission provided by the issuing court; and

                     (c)  ensure that the young person understands the information provided to them under paragraphs (a) and (b) (taking into account the person’s age, language skills, mental capacity and any other relevant factor).

             (4)  Subregulation (3) does not apply if the actions of the young person make it impracticable for the AFP member to comply with that subregulation.

Informing a parent or guardian of the young person

             (5)  An AFP member must take reasonable steps to:

                     (a)  inform at least one parent or guardian of the young person of the request; and

                     (b)  give the parent or guardian the relevant legal aid commission’s contact details (including the details mentioned in paragraph (3)(b)).

             (6)  The AFP member or legal representative complying with subregulation (2), (3) or (5) must do so as soon as practicable after the issuing court decides to make the request and at least 48 hours before the next day when the court will conduct proceedings relating to the control order.

Division 2Preventative detention orders

4  Preventative detention orders—corresponding State preventative detention law

             (1)  For the definition of corresponding State preventative detention law in subsection 100.1(1) of the Code, a law of a State or Territory that is set out in Part 1 of Schedule 1 is declared to correspond to Division 105 of the Code.

             (2)  For the definition of corresponding State preventative detention law in subsection 100.1(1) of the Code, particular provisions of a law of a State or Territory that are set out in Part 2 of Schedule 1 are declared to correspond to Division 105 of the Code.

4A  Continuing detention order proceedings—matters court may take into account in determining whether circumstances beyond offender’s control

                   For the purposes of paragraph 105A.15A(3)(a) of the Code, the following matters are prescribed as matters that a Supreme Court of a State or Territory may take into account in determining whether circumstances are beyond an offender’s control in relation to a continuing detention order proceeding:

                     (a)  an offender’s financial circumstances;

                     (b)  whether an offender has engaged in unreasonable conduct during the proceeding that has contributed to the offender’s inability to afford any or all of the costs and expenses of obtaining legal representation for the proceeding;

                     (c)  both of the following:

                              (i)  whether an offender has made any efforts to obtain legal aid or legal assistance;

                             (ii)  the outcomes of any such efforts;

                     (d)  any other matter that the Court considers relevant.

4B  Continuing detention orders—sharing information

                   The following persons are prescribed for the purposes of subsections 105A.19(1) and (3) of the Code:

                     (a)  a senior executive AFP employee or an AFP employee who is acting as, or performing the duties of, a senior executive AFP employee (all within the meaning of the Australian Federal Police Act 1979);

                     (b)  a member of the police force or police service of a State or Territory;

                     (c)  an officer or employee of a State or Territory, or of an authority of a State or Territory, whose duties relate to corrective services (including prison medical, psychological and psychiatric services), justice or parole;

                     (d)  a person who provides services for, or on behalf of:

                              (i)  a State or Territory; or

                             (ii)  an authority of a State or Territory;

                            in relation to corrective services (including prison medical, psychological and psychiatric services), justice or parole;

                     (e)  the Director of Public Prosecutions or a person performing a similar function under a law of a State or Territory;

                      (f)  a member of the staff of the Office of the Director of Public Prosecutions (within the meaning of the Director of Public Prosecutions Act 1983) or of a similar body established under a law of a State or Territory;

                     (g)  the Director‑General of the Australian Security Intelligence Organisation, a Deputy Director‑General of the Australian Security Intelligence Organisation, an ASIO employee or an ASIO affiliate (all within the meaning of the Australian Security Intelligence Organisation Act 1979);

                     (h)  an employee of a Department administered by the Minister responsible for administering:

                              (i)  the Migration Act 1958; or

                             (ii)  the Australian Citizenship Act 2007.

Part 3Dangers to the community

Division 1Cross‑border firearms trafficking

5  Cross‑border firearms trafficking

                   For the definition of firearm law in subsections 360.2(3) and 360.3(2) of the Code, the Acts, and any regulations made under those Acts, mentioned in Schedule 2 are prescribed.

Division 2Serious drugs and precursors

5A  Controlled drugs

             (1)  For paragraph 301.1(1)(a) of the Code, a drug listed in column 1 of an item in Schedule 3 is a controlled drug.

             (2)  For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity listed in column 2 of an item in Schedule 3 is the commercial quantity of the controlled drug listed in column 1 of that item.

             (3)  For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity listed in column 3 of an item in Schedule 3 is the marketable quantity of the controlled drug listed in column 1 of that item.

             (4)  For paragraph (a) of item 1 of the table in section 301.12 of the Code, the quantity listed in column 4 of an item in Schedule 3 is the trafficable quantity of the controlled drug listed in column 1 of that item.

5B  Controlled plants

             (1)  For paragraph 301.2(1)(a) of the Code, a growing plant listed in column 1 of an item in the following table is a controlled plant.

 

Controlled plants and quantities

Item

Column 1

Column 2

Column 3

Column 4

 

Controlled plant

Commercial quantity

Marketable quantity

Trafficable quantity

1

Any plant of the genus Cannabis

250 kg or
1,000 plants

25 kg or
100 plants

250 g or
10 plants

             (2)  For paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity listed in column 2 of an item in the table in subregulation (1) is a commercial quantity of the controlled plant listed in column 1 of that item.

             (3)  For paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity listed in column 3 of an item in the table in subregulation (1) is a marketable quantity of the controlled plant listed in column 1 of that item.

             (4)  For paragraph (a) of item 1 of the table in section 301.12 of the Code, a quantity listed in column 4 of an item in the table in subregulation (1) is the trafficable quantity of the controlled plant listed in column 1 of that item.

5C  Controlled precursors

             (1)  For paragraph 301.3(1)(a) of the Code, a precursor listed in column 1 of an item in the following table is a controlled precursor.

 

Controlled precursors and quantities

Item

Column 1

Column 2

Column 3

 

Controlled precursor

Commercial quantity (kilograms)

Marketable quantity (grams)

1

Ephedrine

1.2

400.0

2

Ergometrine

0.006

0.15

3

Ergotamine

0.01

0.25

4

Isosafrole

1.45

290.0

5

Lysergic acid

0.003

0.075

6

3,4‑Methylenedioxyphenylacetic acid

1.5

300.0

7

3,4‑Methylenedioxyphenyl‑2‑propanone

0.75

150.0

8

Phenylacetic acid

4.05

1,350.0

9

Phenylpropanolamine

1.2

400.0

10

Phenyl‑2‑propanone

2.03

675.0

11

Piperonal

1.6

320.0

12

Pseudoephedrine

1.2

400.0

13

Safrole

2.85

570.0

Note:          A salt or ester of a precursor listed in column 1 of the table is also a controlled precursor: see paragraph 301.3(b) of the Code.

             (2)  For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity listed in column 2 of an item in the table in subregulation (1) is the commercial quantity of the controlled precursor listed in column 1 of that item.

             (3)  For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity listed in column 3 of an item in the table in subregulation (1) is the marketable quantity of the controlled precursor listed in column 1 of that item.

5D  Border controlled drugs

             (1)  For paragraph 301.4(a) of the Code, a drug listed in column 1 of an item in Schedule 4 is a border controlled drug.

             (2)  For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity listed in column 2 of an item in Schedule 4 is the commercial quantity of the border controlled drug listed in column 1 of that item.

             (3)  For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity listed in column 3 of an item in Schedule 4 is the marketable quantity of the border controlled drug listed in column 1 of that item.

5E  Border controlled plants

             (1)  For paragraph 301.5(a) of the Code, a growing plant listed in column 1 of an item in the following table is a border controlled plant.

 

Border controlled plants and quantities

Item

Column 1

Column 2

Column 3

 

Border controlled plant

Commercial quantity

Marketable quantity

1

Any plant of the genus Cannabis

250 kg or 1,000 plants

25 kg or 100 plants

2

Any plant of the genus Erythroxylon (also known as Erythroxylum) from which cocaine can be extracted either directly or by chemical transformation

 

80 kg

3

Any plant of the genus Lophophora

 

 

4

Any plant of the species Papaver bracteatum

 

10 kg

5

Any plant of the species Papaver somniferum

 

10 kg

6

Any plant of the species Piptagenia peregrine

 

 

7

Any plant of the species Psilocybe

 

 

             (2)  For paragraph (a) of item 1 of the table in section 301.10 of the Code, a quantity (if any) listed in column 2 of an item in the table in subregulation (1) is a commercial quantity of the border controlled plant listed in column 1 of that item.

             (3)  For paragraph (a) of item 1 of the table in section 301.11 of the Code, a quantity (if any) listed in column 3 of an item in the table in subregulation (1) is a marketable quantity of the border controlled plant listed in column 1 of that item.

5F  Border controlled precursors

             (1)  For paragraph 301.6(1)(a) of the Code, a precursor listed in column 1 of an item in the following table is a border controlled precursor.

 

Border controlled precursors and quantities

Item

Column 1

Column 2

Column 3

 

Border controlled precursor

Commercial quantity (kilograms)

Marketable quantity (grams)

1

N‑Acetylanthranilic acid

 

 

2

Any plant of the species Ephedra

 

 

3

Ephedrine

1.2

3.2

4

Ergometrine

0.006

0.006

5

Ergotamine

0.01

0.01

6

Isosafrole

1.45

1.45

7

Lysergic acid

0.003

0.003

8

3,4‑Methylenedioxyphenyl‑2‑propanone

0.75

0.75

9

Phenylacetic acid

4.05

10.8

10

Phenylpropanolamine

1.2

3.2

11

Phenyl‑2‑propanone

2.03

5.4

12

Piperonal

1.6

1.6

13

Pseudoephedrine

1.2

3.2

14

Safrole

2.85

2.85

Note:          A salt or ester of a precursor listed in column 1 of the table and an immediate precursor of a precursor listed in column 1 of the table is a border controlled precursor: see paragraphs 301.6(1)(b) and (c) of the Code.

             (2)  For paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity (if any) listed in column 2 of an item in the table in subregulation (1) is the commercial quantity of the border controlled precursor listed in column 1 of that item.

             (3)  For paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity (if any) listed in column 3 of an item in the table in subregulation (1) is the marketable quantity of the border controlled precursor listed in column 1 of that item.

Division 3Psychoactive substances

5G  Importing psychoactive substances

             (1)  For paragraph 320.2(2)(l) of the Code, a substance that is imported into Australia in accordance with the conditions set out in subregulation (2) is prescribed.

             (2)  For the purpose of subregulation (1), the conditions are that:

                     (a)  the person importing the substance (the importer) is the holder of a licence to import drugs granted by the Health Secretary or an authorised person under subregulation 5(5) of the Customs (Prohibited Imports) Regulations 1956; and

                     (b)  the importer:

                              (i)  is, or is employed by, a forensic laboratory and is importing the substance for the purposes of forensic analysis; or

                             (ii)  is the Australian Federal Police, or a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or

                            (iii)  is the Commissioner or a Deputy Commissioner of the Australian Federal Police, or is the head or deputy head (however described) of a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or

                            (iv)  is, or is employed by, a medical research facility and is importing the substance for the purposes of medical research; or

                             (v)  is, or is employed by, a scientific research facility and is importing the substance for the purposes of scientific research; or

                            (vi)  is, or is employed by, an entity that imports drugs on behalf of a person or body mentioned in subparagraph (i), (ii), (iii), (iv) or (v), being a person or body that also holds a licence of a kind mentioned in paragraph (a), and is importing the substance at the written request of the person or body; and

                     (c)  before the substance is imported, the importer gives the Health Secretary or an authorised person a written notice about the proposed importation that includes:

                              (i)  the identity and amount of the substance being imported; and

                             (ii)  the purpose of the importation; and

                            (iii)  a 30‑day period during which the importation is likely to occur; and

                            (iv)  the importer’s name and import licence number; and

                             (v)  if subparagraph (b)(i), (iv), (v) or (vi) applies and the importer is employed by the body mentioned in the applicable subparagraph—the name of the importer’s employer; and

                            (vi)  any other information required by the Health Secretary.

             (3)  For the purpose of paragraph (2)(c), the Health Secretary may determine:

                     (a)  information to be included in a notice; and

                     (b)  the way a notice may be given to the Health Secretary or an authorised person.

             (4)  In this regulation:

drug has the same meaning as in subregulation 5(20) of the Customs (Prohibited Imports) Regulations 1956.

5H  Importing substances represented to be serious drug alternatives

             (1)  For paragraph 320.3(3)(f) of the Code, a substance that is imported into Australia in accordance with the conditions set out in subregulation (2) is prescribed.

             (2)  For the purpose of subregulation (1), the conditions are that:

                     (a)  the person importing the substance (the importer) is the holder of a licence to import drugs granted by the Health Secretary or an authorised person under subregulation 5(5) of the Customs (Prohibited Imports) Regulations 1956; and

                     (b)  the importer:

                              (i)  is, or is employed by, a forensic laboratory and is importing the substance for the purposes of forensic analysis; or

                             (ii)  is the Australian Federal Police, or a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or

                            (iii)  is the Commissioner or a Deputy Commissioner of the Australian Federal Police, or is the head or deputy head (however described) of a police force of a State or Territory, and is importing the substance for the purposes of law enforcement; or

                            (iv)  is, or is employed by, a medical research facility and is importing the substance for the purposes of medical research; or

                             (v)  is, or is employed by, a scientific research facility and is importing the substance for the purposes of scientific research; or

                            (vi)  is, or is employed by, an entity that imports drugs on behalf of a person or body mentioned in subparagraph (i), (ii), (iii), (iv) or (v), being a person or body that also holds a licence of a kind mentioned in paragraph (a), and is importing the substance at the written request of the person or body; and

                     (c)  before the substance is imported, the importer gives the Health Secretary or an authorised person a written notice about the proposed importation that includes:

                              (i)  the identity and amount of the substance being imported; and

                             (ii)  the purpose of the importation; and

                            (iii)  a 30‑day period during which the importation is likely to occur; and

                            (iv)  the importer’s name and import licence number; and

                             (v)  if subparagraph (b)(i), (iv), (v) or (vi) applies and the importer is employed by the body mentioned in the applicable subparagraph—the name of the importer’s employer; and

                            (vi)  any other information required by the Health Secretary.

             (3)  For the purpose of paragraph (2)(c), the Health Secretary may determine:

                     (a)  information to be included in a notice; and

                     (b)  the way a notice may be given to the Health Secretary or an authorised person.

             (4)  In this regulation:

drug has the same meaning as in subregulation 5(20) of the Customs (Prohibited Imports) Regulations 1956.

Part 4National infrastructure

  

6  Dangerous goods

                   For subparagraph 471.15(1)(b)(ii) of the Code, the following substances and things must not, without exception, be carried by post:

                     (a)  gas that is so toxic or corrosive to humans as to pose a hazard to health;

                     (b)  a thermally unstable substance that is likely to undergo a strongly exothermic decomposition;

                     (c)  a substance that ignites or self‑heats when in contact with air.

Part 5Application and transitional provisions

  

7  Application of the Criminal Code Amendment (Control Orders—Legal Representation for Young People) Regulations 2017

             (1)  The amendments made by items 1 and 2 of Schedule 1 to the Criminal Code Amendment (Control Orders—Legal Representation for Young People) Regulations 2017 apply in relation to the parts of a proceeding that occur after the commencement of that instrument if:

                     (a)  the proceeding commenced before or after the commencement of that instrument; and

                     (b)  the proceeding relates to a control order made on or after 30 November 2016; and

                     (c)  the control order was, or is, requested (however described) on or after 30 November 2016.

             (2)  To avoid doubt, those amendments apply in accordance with subregulation (1) regardless of when the conduct to which that request relates occurred or occurs.

Note:          The conduct may have occurred before or after 30 November 2016.


Schedule 1Corresponding State preventative detention law

(regulation 4)

Part 1Laws of a State or Territory

 

Item

Declared laws

1

Terrorism (Preventative Detention) Act 2005 (Qld)

1A

Terrorism (Preventative Detention) Act 2006 (WA)

2

Terrorism (Preventative Detention) Act 2005 (SA)

3

Terrorism (Preventative Detention) Act 2005 (Tas)

Part 2Particular provisions of a law of a State or Territory

 

Item

Declared provisions

1

Part 2A, Terrorism (Police Powers) Act 2002 (NSW)

2

Part 2A, Terrorism (Community Protection) Act 2003 (Vic)

3

Part 2, Terrorism (Extraordinary Temporary Powers) Act 2006 (ACT)

4

Part 2B, Terrorism (Emergency Powers) Act (NT)

Schedule 2Cross‑border firearms trafficking

(regulation 5)

  

 

Item

Act

1

Firearms Act 1996 (NSW)

2

Firearms Act 1996 (Vic)

3

Weapons Act 1990 (Qld)

4

Firearms Act 1973 (WA)

5

Firearms Act 1977 (SA)

6

Firearms Act 1996 (Tas)

7

Firearms Act 1996 (ACT)

8

Firearms Act 1997 (NT)

9

Firearms Act 1997 (Norfolk Island)

Schedule 3Controlled drugs

Note:       See regulation 5A.

  

 

Controlled drugs and quantities

Item

Column 1

Column 2

Column 3

Column 4

 

Controlled drug

Commercial quantity (kilograms)

Marketable quantity (grams)

Trafficable quantity (grams)

1

Acetorphine

2.0

250.0

2.0

2

Acetyl‑alpha‑methylfentanyl

0.005

2.5

0.005

3

4‑Acetoxy‑N, N‑dimethyltryptamine (4‑AcO‑DMT)

2.0

250.0

2.0

4

4‑Acetoxy‑N‑methyl‑N‑ethyltryptamine (4‑AcO‑MET)

2.0

250.0

2.0

5

Acetylcodeine

2.0

250.0

2.0

6

Acetyldihydrocodeine

2.0

250.0

2.0

7

Acetylmethadol

2.0

250.0

2.0

8

Allylprodine

2.0

250.0

2.0

9

Alphacetylmethadol

10.0

5,000.0

10.0

10

Alphameprodine

0.2

100.0

0.2

11

Alphamethadol

0.2

100.0

0.2

12

alpha‑Methylfentanyl

0.005

2.5

0.005

13

alpha‑Methylthiofentanyl

0.005

2.5

0.005

14

alpha‑Pyrrolidinobutiophenone (α‑PBP)

0.75

250.0

0.75

15

alpha‑Pyrrolidinopropiophenone (α‑PPP)

0.75

250.0

0.75

16

alpha‑Pyrrolidinovalerophenone (α‑PVP)

0.75

250.0

0.75

17

Alphaprodine

25.0

12,500.0

25.0

18

5‑(2‑Aminopropyl)‑2,3‑dihydro‑1h‑indene (5‑APDI)

0.75

250.0

0.75

19

6‑(2‑Aminopropyl)‑2,3‑dihydrobenzofuran (6‑APDB)

0.75

250.0

0.75

20

Amphetamine

0.75

250.0

2.0

21

Anileridine

25.0

12,500.0

25.0

22

Barbiturates

5.0

 

5.0

23

Benzethidine

10.0

5,000.0

10.0

24

1‑(Benzofuran‑6‑yl) propan‑2‑amine (6‑APB)

0.75

250.0

0.75

25

Benzoylecgonine

2.0

250.0

2.0

26

Benzylmorphine

5.0

2,500.0

5.0

27

Benzylpiperazine

0.75

250.0

2.0

28

Betacetylmethadol

5.0

2,500.0

5.0

29

beta‑Hydroxyfentanyl

0.005

2.5

0.005

30

beta‑Hydroxy‑3‑methylfentanyl

0.005

2.5

0.005

31

beta‑Keto‑methylbenzodioxolylpentanamine (pentylone)

0.75

250.0

0.75

32

beta‑Keto‑N‑methyl‑3,4‑benzodioxyolylbutanamine (butylone)

0.75

250.0

0.75

33

Betameprodine

5.0

2,500.0

5.0

34

Betamethadol

5.0

2,500.0

5.0

35

Betaprodine

5.0

2,500.0

5.0

36

Bezitramide

5.0

2,500.0

5.0

37

2‑Bromoamphetamine

0.75

250.0

0.75

38

3‑Bromoamphetamine

0.75

250.0

0.75

39

4‑Bromoamphetamine

0.75

250.0

0.75

40

4‑Bromo‑2,5‑dimethoxyamphetamine

0.5

100.0

0.5

41

2‑Bromo‑5‑methoxymethcathinone

0.75

250.0

0.75

42

2‑Bromomethamphetamine

0.75

250.0

0.75

43

3‑Bromomethamphetamine

0.75

250.0

0.75

44

4‑Bromomethamphetamine

0.75

250.0

0.75

45

2‑Bromomethcathinone

0.75

250.0

0.75

46

3‑Bromomethcathinone

0.75

250.0

0.75

47

4‑Bromomethcathinone

0.75

250.0

0.75

48

Bufotenine

2.0

250.0

2.0

49

Bupropion

0.75

250.0

0.75

50

Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre)

125.0

25,000.0

250.0

51

Cannabis resin

125.0

25,000.0

20.0

52

Cathinone

0.75

250.0

0.75

53

1‑(4‑Chloro‑2,5‑dimethoxyphenyl)‑2‑ethenamine (2C‑C)

0.5

100.0

0.5

54

2‑Chloroamphetamine

0.75

250.0

0.75

55

3‑Chloroamphetamine

0.75

250.0

0.75

56

4‑Chloroamphetamine

0.75

250.0

0.75

57

2‑Chloromethamphetamine

0.75

250.0

0.75

58

3‑Chloromethamphetamine

0.75

250.0

0.75

59

4‑Chloromethamphetamine

0.75

250.0

0.75

60

4‑Chloro‑N‑ethylamphetamine

0.75

250.0

0.75

61

2‑Chloromethcathinone

0.75

250.0

0.75

62

3‑Chloromethcathinone

0.75

250.0

0.75

63

4‑Chloromethcathinone

0.75

250.0

0.75

64

4‑Chlorophenyl‑1‑methoxypropan‑2‑amine

0.75

250.0

0.75

65

Chlorphentermine

2.0

250.0

2.0

66

Clonitazene

5.0

100.0

5.0

67

Cocaine

2.0

250.0

2.0

68

Codeine

10.0

5,000.0

10.0

69

Codeine‑N‑oxide

10.0

5,000.0

10.0

70

Codoxime

10.0

5,000.0

10.0

71

Desomorphine

2.0

250.0

2.0

72

Dexamphetamine

2.0

250.0

2.0

73

Dextromoramide

2.0

250.0

2.0

74

Diampromide

5.0

2,500.0

5.0

75

Diethylpropion (N, N‑Diethylcathinone)

5.0

2,500.0

5.0

76

Diethylthiambutene

5.0

2,500.0

5.0

77

N,N‑Diethyltryptamine

2.0

250.0

2.0

78

Difenoxin

2.0

250.0

2.0

79

1‑(2,3‑Dihydro‑1‑benzofuran‑5‑yl)propan‑2‑amine (5‑APDB)

0.75

250.0

0.75

80

Dihydrocodeine

10.0

5,000.0

10.0

81

Dihydromorphine

10.0

5,000.0

10.0

82

Dimenoxadol

10.0

5,000.0

10.0

83

Dimepheptanol

10.0

5,000.0

10.0

84

2,5‑Dimethoxy‑4‑bromophenethylamine (2C‑B)

0.5

100.0

0.5

85

2,5‑Dimethoxy‑4‑ethylphenethylamine (2C‑E)

0.5

100.0

0.5

86

2,5‑Dimethoxy‑4‑iodophenethylamine (2C‑I)

0.5

100.0

0.5

87

2,5‑Dimethoxy‑4‑methylamphetamine (STP, DOM)

0.75

250

0.75

88

2,5‑Dimethoxy‑4‑methylphenethylamine (2C‑D)

0.5

100.0

0.5

89

2,5‑Dimethoxy‑4‑nitrophenethylamine (2C‑N)

0.5

100.0

0.5

90

2,5‑Dimethoxy‑4‑(n)‑propylphenethylamine (2C‑P)

0.5

100.0

0.5

91

3,4‑Dimethoxymethcathinone

0.75

250.0

0.75

92

1‑Dimethylamino‑1,2‑diphenylethane

5.0

2,500.0

5.0

93

N,N‑Dimethylamphetamine

0.75

250.0

0.75

94

N, N‑Dimethylcathinone

0.75

250.0

0.75

95

1,1‑Dimethylheptyl‑11‑hydroxytetrahydrocannabinol (HU‑210)

5.0

1,000.0

5.0

96

3,4‑Dimethylmethcathinone

0.75

250.0

0.75

97

Dimethylthiambutene

20.0

10,000.0

20.0

98

N,N‑Dimethyltryptamine

2.0

250.0

2.0

99

Dioxaphetyl butyrate

2.0

250.0

2.0

100

Diphenoxylate

2.0

250.0

2.0

101

Dipipanone

10.0

5,000.0

10.0

102

Drotebanol

2.0

250.0

2.0

103

Ecgonine

10.0

5,000.0

10.0

104

Ethchlorvynol

50.0

 

50.0

105

Ethinamate

50.0

 

50.0

106

N‑Ethylcathinone

0.75

250.0

0.75

107

Ethylmethylthiambutene

10.0

5,000.0

10.0

108

Ethylmorphine

2.0

250.0

2.0

109

3‑(2‑Ethylphenyl)‑2‑methyl‑quinazolin‑4‑one (Etaqualone)

5.0

 

5.0

110

Etonitazene

5.0

2,500.0

5.0

111

Etorphine

5.0

2,500.0

5.0

112

Etoxeridine

5.0

2,500.0

5.0

113

Fentanyl

0.005

2.5

0.005

114

4‑Fluoro‑2,5‑dimethoxyphenethylamine (2C‑F)

0.5

100.0

0.5

115

2‑Fluoroamphetamine

0.75

250.0

0.75

116

3‑Fluoroamphetamine

0.75

250.0

0.75

117

4‑Fluoroamphetamine

0.75

250.0

0.75

118

2‑Fluoromethamphetamine

0.75

250.0

0.75

119

3‑Fluoromethamphetamine

0.75

250.0

0.75

120

4‑Fluoromethamphetamine

0.75

250.0

0.75

121

2‑Fluoromethcathinone

0.75

250.0

0.75

122

3‑Fluoromethcathinone

0.75

250.0

0.75

123

4‑Fluoromethcathinone

0.75

250.0

0.75

124

Furethidine

1.0

500.0

1.0

125

Gammabutyrolactone (GBL)

1.0

250.0

0.5

126

Glutethimide

50.0

 

50.0

127

Heroin (diacetylmorphine)

1.5

250.0

2.0

128

Hydrocodone

2.0

250.0

2.0

129

Hydromorphinol

2.0

250.0

2.0

130

Hydromorphone

2.0

250.0

2.0

131

Hydroxyamphetamine

2.0

250.0

2.0

132

4‑Hydroxybutanoic acid (GHB)

1.0

250.0

0.5

133

p‑Hydroxyephedrine

2.0

250.0

2.0

134

Hydroxypethidine

0.75

250.0

0.75

135

2‑Iodoamphetamine

0.75

250.0

0.75

136

3‑Iodoamphetamine

0.75

250.0

0.75

137

4‑Iodoamphetamine

0.75

250.0

0.75

138

2‑Iodomethamphetamine

0.75

250.0

0.75

139

3‑Iodomethamphetamine

0.75

250.0

0.75

140

4‑Iodomethamphetamine

0.75

250.0

0.75

141

2‑Iodomethcathinone

0.75

250.0

0.75

142

3‑Iodomethcathinone

0.75

250.0

0.75

143

4‑Iodomethcathinone

0.75

250.0

0.75

144

Isomethadone

2.0

250.0

2.0

145

4‑Isopropoxy‑2,5‑dimethoxyphenethylamine (2C‑O‑4)

0.5

100.0

0.5

146

Ketamine

1.0

500.0

3.0

147

Ketobemidone

2.0

250.0

2.0

148

Levophenacylmorphan

2.0

250.0

2.0

149

Levomethorphan

2.0

250.0

2.0

150

Levorphanol, but not including dextrorphan

1.0

500.0

1.0

151

Lysergamides

0.01

 

0.01

152

Lysergide (LSD)

0.002

0.05

0.002

153

Meprobamate

50.0

 

50.0

154

Mescaline

7.5

3.75

7.5

155

Metazocine

7.0

3,500.0

7.0

156

Methadone

2.0

250.0

2.0

157

Methamphetamine

0.75

250.0

2.0

158

Methaqualone

5.0

 

5.0

159

Methcathinone

0.75

250.0

2.0

160

Methorphan, but not including dextromethorphan

2.0

250.0

2.0

161

4’‑Methoxy‑alpha‑pyrrolidinopropiophenone (MOPPP)

0.75

250.0

0.75

162

4‑Methoxyamphetamine

0.75

250.0

0.75

163

4‑Methoxymethamphetamine

0.75

250.0

0.75

164

4‑Methoxymethcathinone

0.75

250.0

0.75

165

4’‑Methyl‑alpha‑pyrrolidinobutiophenone (MPBP)

0.75

250.0

0.75

166

4’‑Methyl‑alpha‑pyrrolidinohexiophenone (MPHP)

0.75

250.0

0.75

167

4’‑Methyl‑alpha‑pyrrolidinopropiophenone (MPPP)

0.75

250.0

0.75

168

N‑Methyl butylone

0.75

250.0

0.75

169

2‑Methylamino‑1‑phenylbutan‑1‑ one (buphedrone)

0.75

250.0

0.75

170

4‑Methylamphetamine

0.75

250.0

0.75

171

3,4‑Methylenedioxyamphetamine (MDA)

0.75

100.0

0.5

172

4‑Methylethcathinone

0.75

250.0

0.75

173

3,4‑Methylenedioxymethamphetamine (MDMA)

0.5

100.0

0.5

174

Methyldesorphine

2.0

250.0

2.0

175

Methyldihydromorphine

2.0

250.0

2.0

176

3,4‑Methylenedioxyethcathinone (MDEC)

0.75

250.0

0.75

177

3,4‑Methylenedioxymethcathinone (MDMC)

0.75

250.0

0.75

178

3,4‑Methylenedioxypyrovalerone (MDPV)

0.75

250.0

0.75

179

3’,4’‑Methylenedioxy‑alpha‑pyrrolidinobutiophenone (MDPBP)

0.75

250.0

0.75

180

3’,4’‑Methylenedioxy‑alpha‑pyrrolidinopropiophenone (MDPPP)

0.75

250.0

0.75

181

3‑Methylfentanyl

0.005

2.5

0.005

182

4‑Methylmethamphetamine

0.75

250.0

0.75

183

4‑Methylmethcathinone (4‑MMC)

0.75

250.0

2.0

184

Methylphenidate

2.0

250.0

2.0

185

1‑Methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP)

2.0

250.0

2.0

186

4‑Methylthioamphetamine (4‑MTA)

0.75

250.0

0.75

187

4‑Methylthiobutylamphetamine (4‑MTBA)

0.75

250.0

0.75

188

4‑Methylthiodimethamphetamine (4‑MTDMA)

0.75

250.0

0.75

189

4‑Methylthioethylamphetamine (4‑MTEA)

0.75

250.0

0.75

190

3‑Methylthiofentanyl

0.005

2.5

0.005

191

4‑Methylthiomethamphetamine (4‑MTMA)

0.75

250.0

0.75

192

4‑Methylthiopropylamphetamine (4‑MTPA)

0.75

250.0

0.75

193

Methyprylon

50.0

 

50.0

194

Metopon

2.0

250.0

2.0

195

Monoacetylmorphines

2.0

250.0

2.0

196

Moramide

2.0

250.0

2.0

197

Morphan, but not including dextrorphan

2.0

250.0

2.0

198

Morpheridine

2.0

250.0

2.0

199

Morphine

1.5

250.0

1.5

200

Morphine‑N‑oxide

2.0

250.0

2.0

201

Myrophine

20.0

 

20.0

202

Nicocodine

2.0

250.0

2.0

203

Nicodicodine

2.0

250.0

2.0

204

Nicomorphine

2.0

250.0

2.0

205

Noracymethadol

2.0

250.0

2.0

206

Norcodeine

2.0

250.0

2.0

207

Norlevorphanol

2.0

250.0

2.0

208

Normethadone

5.0

2,500.0

5.0

209

Normorphine

20.0

 

20.0

210

Norpipanone

10.0

5,000.0

10.0

211

Opium

20.0

10,000.0

20.0

212

Oripavine

2.0

250.0

2.0

213

Oxycodone

5.0

2,500.0

5.0

214

Oxymorphone

2.0

250.0

2.0

215

para‑Fluorofentanyl

0.005

2.5

0.005

216

Pentazocine

20.0

 

20.0

217

Pethidine

10.0

5,000.0

10.0

218

Phenadoxone

10.0

5,000.0

10.0

219

Phenampromide

10.0

5,000.0

10.0

220

Phenazocine

1.0

500.0

1.0

221

Phencyclidine

2.0

250.0

2.0

222

Phendimetrazine

5.0

2,500.0

5.0

223

Phenmetrazine

5.0

2,500.0

5.0

224

Phenomorphan

5.0

2,500.0

5.0

225

Phenoperidine

1.0

500.0

1.0

226

Phentermine

5.0

2,500.0

5.0

227

1‑Phenylethyl‑4‑phenyl‑4‑acetoxypiperidine (PEPAP)

2.0

250.0

2.0

228

Pholcodine

5.0

2,500.0

5.0

229

Piminodine

10.0

5,000.0

10.0

230

Pipradrol

1.0

500.0

1.0

231

Piritramide

1.0

500.0

1.0

232

Proheptazine

1.0

500.0

1.0

233

Properidine

25.0

12,500.0

25.0

234

Propiram

10.0

5,000.0

10.0

235

Psilocine

2.0

1,000.0

2.0

236

Psilocybine

2.0

1,000.0

2.0

237

Pyrovalerone

0.75

250.0

0.75

238

Tetrahydrocannabinols (THC)

5.0

1,000.0

2.0

239

Thebacon

2.0

250.0

2.0

240

Thebaine

2.0

250.0

2.0

241

Thiofentanyl

0.005

2.5

0.005

242

2,4,5‑Trimethoxyphenethylamine (2C‑O)

0.5

100.0

0.5

243

Trimeperidine

10.0

5,000.0

10.0

244

2,3,4‑Trimethoxyamphetamine

0.75

250.0

0.75

245

2,3,5‑Trimethoxyamphetamine

0.75

250.0

0.75

246

2,3,6‑Trimethoxyamphetamine

0.75

250.0

0.75

247

2,4,5‑Trimethoxyamphetamine

0.75

250.0

0.75

248

2,4,6‑Trimethoxyamphetamine

0.75

250.0

0.75

249

3,4,5‑Trimethoxyamphetamine

0.75

250.0

0.75

Note:       A drug analogue of a drug listed in column 1 of the table is a controlled drug: see paragraph 301.1(b) of the Code.

Schedule 4Border controlled drugs

Note:       See regulation 5D.

  

Border controlled drugs and quantities

Item

Column 1

Column 2

Column 3

 

Border controlled drug

Commercial quantity (kilograms)

Marketable quantity (grams)

1

Acetorphine

2.0

2.0

2

Acetyl‑alpha‑methylfentanyl

0.005

0.005

3

Acetylcodeine

2.0

2.0

4

Acetyldihydrocodeine

2.0

2.0

5

Acetylmethadol

2.0

2.0

6

Allylprodine

2.0

2.0

7

Alphacetylmethadol

10.0

10.0

8

Alphameprodine

0.2

0.2

9

Alphamethadol

0.2

0.2

10

alpha‑Methylfentanyl

0.005

0.005

11

alpha‑Methylthiofentanyl

0.005

0.005

12

Alphaprodine

25.0

25.0

13

Amphecloral

2.0

2.0

14

3‑(2‑Aminopropyl)indole (alpha‑methyltryptamine (AMT))

2.0

2.0

15

5‑(2‑Aminopropyl)‑2,3‑dihydro‑1h‑indene (5‑APDI)

0.75

0.5

16

Amphetamine

0.75

2.0

17

Anileridine

25.0

25.0

18

Barbiturates

5.0

50.0

19

Benzethidine

10.0

10.0

20

1‑(Benzofuran‑6‑yl) propan‑2‑amine (6‑APB)

0.75

0.5

21

Benzoylecgonine

2.0

2.0

22

Benzylmorphine

5.0

5.0

23

Benzylpiperazine

0.75

2.0

24

Betacetylmethadol

5.0

5.0

25

beta‑Hydroxyfentanyl

0.005

0.005

26

beta‑Hydroxy‑3‑methylfentanyl

0.005

0.005

27

beta‑Keto‑N‑methyl‑3,4‑benzodioxyolylbutanamine (butylone)

0.75

2.0

28

Betameprodine

5.0

5.0

29

Betamethadol

5.0

5.0

30

Betaprodine

5.0

5.0

31

Bezitramide

5.0

5.0

32

4‑Bromo‑2,5‑dimethoxyamphetamine

0.5

0.5

32A

2‑(4‑bromo‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl]ethanamine (25‑B‑NBOMe)

0.002

0.002

33

Bufotenine

2.0

2.0

34

Cannabinoids (other than a Cannabinoid of a kind that can be obtained from a plant that is not a Cannabis plant)

2.0

2.0

35

Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre)

100.0

25,000.0

36

Cannabis resin

50.0

20.0

37

Cathinone

0.75

2.0

38

1‑(4‑Chloro‑2,5‑dimethoxyphenyl)‑2‑ethenamine (2C‑C)

0.5

0.5

38A

2‑(4‑chloro‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl]ethanamine (25‑C‑NBOMe)

0.002

0.002

39

Chlorphentermine

2.0

2.0

40

Clonitazene

5.0

5.0

41

Cocaine

2.0

2.0

42

Codeine

10.0

10.0

43

Codeine‑N‑oxide

10.0

10.0

44

Codoxime

10.0

10.0

45

Desomorphine

2.0

2.0

46

Dexamphetamine

2.0

2.0

47

Dextromoramide

2.0

2.0

48

Diampromide

5.0

5.0

49

Diethylpropion (N, N‑Diethylcathinone)

5.0

5.0

50

Diethylthiambutene

5.0

5.0

51

N,N‑Diethyltryptamine

2.0

2.0

52

Difenoxin

2.0

2.0

53

Dihydrocodeine

10.0

10.0

54

Dihydromorphine

10.0

10.0

55

Dimenoxadol

10.0

10.0

56

Dimepheptanol

10.0

10.0

57

2,5‑Dimethoxy‑4‑bromophenethylamine (2C‑B)

0.5

0.5

58

2,5‑Dimethoxy‑4‑(n)‑butylthiophenethylamine (2C‑T‑9)

0.5

0.5

59

2,5‑Dimethoxy‑4‑ethylphenethylamine (2C‑E)

0.5

0.5

60

2,5‑Dimethoxy‑4‑ethylthiophenethylamine (2C‑T‑2)

0.5

0.5

61

2,5‑Dimethoxy‑4‑iodophenethylamine (2C‑I)

0.5

0.5

62

2,5‑Dimethoxy‑4‑(β‑isobutylthio)phenethylamine (2C‑T‑17)

0.5

0.5

63

2,5‑Dimethoxy‑4‑isopropylthiophenethylamine (2C‑T‑4)

0.5

0.5

64

2,5‑Dimethoxy‑4‑(β‑methoxyethylthio)phenethylamine (2C‑T‑13)

0.5

0.5

65

2,5‑Dimethoxy‑4‑methylamphetamine (STP, DOM)

0.75

2.0

66

2,5‑Dimethoxy‑4‑methylphenethylamine (2C‑D)

0.5

0.5

67

2,5‑Dimethoxy‑4‑nitrophenethylamine (2C‑N)

0.5

0.5

68

2,5‑Dimethoxy‑4‑(n)‑propylphenethylamine (2C‑P)

0.5

0.5

69

2,5‑Dimethoxy‑4‑n‑propylthiophenethylamine (2C‑T‑7)

0.5

0.5

69A

2‑(2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl]ethanamine (25‑H‑NBOMe)

0.002

0.002

70

1‑Dimethylamino‑1,2‑diphenylethane

5.0

5.0

71

1,1‑Dimethylheptyl‑11‑hydroxytetrahydrocannabinol (HU‑210)

5.0

2.0

72

Dimethylthiambutene

20.0

20.0

73

N,N‑Dimethyltryptamine

2.0

2.0

74

Dioxaphetyl butyrate

2.0

2.0

75

Diphenoxylate

2.0

2.0

76

Dipipanone

10.0

10.0

77

Drotebanol

2.0

2.0

78

Ecgonine

10.0

10.0

79

Ethchlorvynol

50.0

50.0

80

Ethinamate

50.0

50.0

81

Ethylmethylthiambutene

10.0

10.0

82

Ethylmorphine

2.0

2.0

83

Etonitazene

5.0

5.0

84

Etorphine

5.0

5.0

85

Etoxeridine

5.0

5.0

86

Fentanyl

0.005

0.005

87

4‑Fluoro‑2,5‑dimethoxyphenethylamine (2C‑F)

0.5

0.5

88

4‑(2‑Fluoroethylthio)‑2,5‑dimethoxyphenethylamine (2C‑T‑21)

0.5

0.5

89

1‑(5‑fluoropentyl)‑3‑(2‑iodobenzyl)indole (AM‑694)

5.0

2.0

90

Furethidine

1.0

1.0

91

Gammabutyrolactone (GBL)

1.0

2.0

92

Glutethimide

50.0

50.0

93

Harmaline

5.0

2.0

94

Harmine

5.0

2.0

95

Heroin (diacetylmorphine)

1.5

2.0

96

Hydrocodone

2.0

2.0

97

Hydromorphinol

2.0

2.0

98

Hydromorphone

2.0

2.0

99

Hydroxyamphetamine

2.0

2.0

100

4‑Hydroxybutanoic acid (GHB)

1.0

2.0

101

2‑[(1R,3S)‑3‑hydroxycyclohexyl]‑5‑(2‑methyloctan‑2‑yl)phenol (CP 47,497)

5.0

2.0

102

2‑[(1R,3S)‑3‑hydroxycyclohexyl]‑5‑(2‑methylnonan‑2‑yl)phenol (CP 47,497‑C8)

5.0

2.0

103

Hydroxypethidine

5.0

5.0

103A

2‑(4‑iodo‑2,5‑dimethoxyphenyl)‑N‑[(2‑methoxyphenyl)methyl]ethanamine (25‑I‑NBOMe)

0.002

0.002

104

Isomethadone

2.0

2.0

105

4‑Isopropoxy‑2,5‑dimethoxyphenethylamine (2C‑O‑4)

0.5

0.5

106

Ketamine

1.0

3.0

107

Ketobemidone

2.0

2.0

108

Levophenacylmorphan

2.0

2.0

109

Levomethorphan

2.0

2.0

110

Levorphanol, but not including dextrorphan

1.0

1.0

111

Lysergamide

0.01

0.1

112

Lysergide (LSD)

0.002

0.002

113

Meprobamate

50.0

50.0

114

Mescaline

7.5

7.5

115

Metazocine

7.0

7.0

116

Methadone

2.0

2.0

117

Methamphetamine

0.75

2.0

118

Methaqualone

5.0

50.0

119

Methcathinone

0.75

2.0

120

Methorphan, but not including dextromethorphan

2.0

2.0

121

5‑Methoxy‑alpha‑methyltryptamine (5‑MeO‑AMT)

2.0

2.0

122

5‑Methoxy‑N,N‑diisopropyltryptamine (5‑MeO‑DiPT)

2.0

2.0

123

4‑Methoxyamphetamine

0.75

2.0

124

4‑Methoxymethamphetamine

0.75

2.0

125

4‑Methylamphetamine

0.75

2.0

126

3,4‑Methylenedioxyamphetamine (MDA)

0.75

0.5

127

2‑(2‑Methoxyphenyl)‑1‑(1‑pentylindol‑3‑yl)ethanone (JWH‑250)

5.0

2.0

128

3,4‑Methylenedioxymethamphetamine (MDMA)

0.5

0.5

129

Methyldesorphine

2.0

2.0

130

Methyldihydromorphine

2.0

2.0

131

3,4‑Methylenedioxypyrovalerone (MDPV)

0.75

2.0

132

3‑Methylfentanyl

0.005

0.005

133

4‑Methylmethamphetamine

0.75

2.0

134

4‑Methylmethcathinone (4‑MMC)

0.75

2.0

135

Methylphenidate

2.0

2.0

136

1‑Methyl‑4‑phenyl‑4‑propionoxypiperidine (MPPP)

2.0

2.0

137

4‑Methylthio‑2,5‑dimethoxyphenethylamine (2C‑T)

0.5

0.5

138

4‑Methylthioamphetamine (4‑MTA)

0.75

2.0

139

4‑Methylthiobutylamphetamine (4‑MTBA)

0.75

2.0

140

4‑Methylthiodimethamphetamine (4‑MTDMA)

0.75

2.0

141

4‑Methylthioethylamphetamine (4‑MTEA)

0.75

2.0

142

3‑Methylthiofentanyl

0.005

0.005

143

4‑Methylthiomethamphetamine (4‑MTMA)

0.75

2.0

144

4‑Methylthiopropylamphetamine (4‑MTPA)

0.75

2.0

145

Methyprylon

50.0

50.0

146

Metopon

2.0

2.0

147

Monoacetylmorphines

2.0

2.0

148

Moramide

2.0

2.0

149

Morphan, but not including dextrorphan

2.0

2.0

150

Morpheridine

2.0

2.0

151

Morphine

1.5

2.0

152

Morphine‑N‑oxide

2.0

2.0

153

(1‑(2‑Morpholin‑4‑ylethyl)indol‑3‑yl)‑napthalen‑1‑ylmethanone (JWH‑200)

5.0

2.0

154

Myrophine

20.0

20.0

155

Napthalen‑1‑yl‑(1‑butylindol‑3‑yl)methanone (JWH‑073)

5.0

2.0

156

Nicocodine

2.0

2.0

157

Nicodicodine

2.0

2.0

158

Nicomorphine

2.0

2.0

159

Noracymethadol

2.0

2.0

160

Norcodeine

2.0

2.0

161

Norlevorphanol

2.0

2.0

162

Normethadone

5.0

5.0

163

Normorphine

20.0

20.0

164

Norpipanone

10.0

10.0

165

Opium

20.0

20.0

166

Oripavine

2.0

2.0

167

Oxycodone

5.0

5.0

168

Oxymorphone

2.0

2.0

169

para‑Fluorofentanyl

0.005

0.005

170

Pentazocine

20.0

20.0

171

1‑Pentyl‑3‑(1‑napthoyl)indol (JWH‑018)

5.0

2.0

172

Pethidine

10.0

10.0

173

1‑Pentyl‑3‑(4‑methyl‑1‑napthoyl)indole (JWH‑122)

5.0

2.0

174

Phenadoxone

10.0

10.0

175

Phenampromide

10.0

10.0

176

Phenazocine

1.0

1.0

177

Phencyclidine

2.0

2.0

178

Phendimetrazine

5.0

5.0

179

Phenmetrazine

5.0

5.0

180

Phenomorphan

5.0

5.0

181

Phenoperidine

1.0

1.0

182

Phentermine

5.0

5.0

183

1‑Phenylethyl‑4‑phenyl‑4‑acetoxypiperidine (PEPAP)

2.0

2.0

184

Pholcodine

5.0

5.0

185

Piminodine

10.0

10.0

186

Pipradrol

1.0

1.0

187

Piritramide

1.0

1.0

188

Proheptazine

1.0

1.0

189

Properidine

25.0

25.0

190

Propiram

10.0

10.0

191

Psilocine

0.1

0.1

192

Psilocybine

0.1

0.1

193

Pyrovalerone

0.75

2.0

194

Tetrahydrocannabinols (THC)

5.0

2.0

195

Thebacon

2.0

2.0

196

Thebaine

2.0

2.0

197

Thiofentanyl

0.005

0.005

198

2,4,5‑Trimethoxyphenethylamine (2C‑O)

0.5

0.5

199

Trimeperidine

10.0

10.0

200

2,3,4‑Trimethoxyamphetamine

0.75

2.0

201

2,3,5‑Trimethoxyamphetamine

0.75

2.0

202

2,3,6‑Trimethoxyamphetamine

0.75

2.0

203

2,4,5‑Trimethoxyamphetamine

0.75

2.0

204

2,4,6‑Trimethoxyamphetamine

0.75

2.0

205

3,4,5‑Trimethoxyamphetamine

0.75

2.0

Note:       A drug analogue of a drug listed in column 1 of the table is a border controlled drug: see paragraph 301.4(b) of the Code.


Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.

 

Endnote 2—Abbreviation key

 

ad = added or inserted

o = order(s)

am = amended

Ord = Ordinance

amdt = amendment

orig = original

c = clause(s)

par = paragraph(s)/subparagraph(s)

C[x] = Compilation No. x

    /sub‑subparagraph(s)

Ch = Chapter(s)

pres = present

def = definition(s)

prev = previous

Dict = Dictionary

(prev…) = previously

disallowed = disallowed by Parliament

Pt = Part(s)

Div = Division(s)

r = regulation(s)/rule(s)

ed = editorial change

reloc = relocated

exp = expires/expired or ceases/ceased to have

renum = renumbered

    effect

rep = repealed

F = Federal Register of Legislation

rs = repealed and substituted

gaz = gazette

s = section(s)/subsection(s)

LA = Legislation Act 2003

Sch = Schedule(s)

LIA = Legislative Instruments Act 2003

Sdiv = Subdivision(s)

(md) = misdescribed amendment can be given

SLI = Select Legislative Instrument

    effect

SR = Statutory Rules

(md not incorp) = misdescribed amendment

Sub‑Ch = Sub‑Chapter(s)

    cannot be given effect

SubPt = Subpart(s)

mod = modified/modification

underlining = whole or part not

No. = Number(s)

    commenced or to be commenced

 

Endnote 3—Legislation history

 

Number and year

Registration

Commencement

Application, saving and transitional provisions

67, 2002

12 Apr 2002

12 Apr 2002

 

248, 2002

21 Oct 2002

21 Oct 2002

249, 2002

21 Oct 2002

21 Oct 2002 (r 2)

250, 2002

27 Oct 2002

27 Oct 2002

269, 2002

14 Nov 2002

14 Nov 2002

270, 2002

14 Nov 2002

14 Nov 2002

271, 2002

14 Nov 2002

14 Nov 2002

272, 2002

14 Nov 2002

14 Nov 2002

30, 2003

7 Mar 2003

7 Mar 2003

43, 2003

27 Mar 2003

27 Mar 2003

59, 2003

11 Apr 2003

11 April 2003

60, 2003

11 Apr 2003

11 April 2003

61, 2003

11 Apr 2003

11 April 2003

62, 2003

11 Apr 2003

11 April 2003

63, 2003

11 Apr 2003

11 April 2003

64, 2003

11 Apr 2003

11 April 2003

184, 2003

18 July 2003

5 June 2003

285, 2003

9 Nov 2003

9 Nov 2003

83, 2004

3 May 2004

3 May 2004

283, 2004

1 Sept 2004

1 Sept 2004

284, 2004

1 Sept 2004

1 Sept 2004

311, 2004

5 Nov 2004

5 Nov 2004

312, 2004

5 Nov 2004

5 Nov 2004

313, 2004

5 Nov 2004

5 Nov 2004

314, 2004

5 Nov 2004

5 Nov 2004

23, 2005

1 Mar 2005 (F2005L00384)

2 Mar 2005

36, 2005

23 Mar 2005 (F2005L00699)

27 Mar 2005

57, 2005

8 Apr 2005 (F2005L00703)

11 Apr 2005

58, 2005

8 Apr 2005 (F2005L00702)

11 Apr 2005

59, 2005

8 Apr 2005 (F2005L00707)

11 Apr 2005

60, 2005

8 Apr 2005 (F2005L00701)

11 Apr 2005

61, 2005

8 Apr 2005 (F2005L00706)

11 Apr 2005

62, 2005

8 Apr 2005 (F2005L00850)

11 Apr 2005

85, 2005

26 May 2005 (F2005L01201)

5 June 2005

86, 2005

26 May 2005 (F2005L01202)

5 June 2005

287, 2005

26 May 2005 (F2005L01203)

5 June 2005

88, 2005

26 May 2005 (F2005L01204)

5 June 2005

214, 2005

6 Oct 2005 (F2005L02976)

7 Oct 2005

298, 2005

16 Dec 2005 (F2005L04036)

17 Dec 2005

178, 2006

14 July 2006 (F2006L01551)

15 July 2006

220, 2006

25 Aug 2006 (F2006L02639)

26 Aug 2006

221, 2006

25 Aug 2006 (F2006L02640)

26 Aug 2006

276, 2006

2 Nov 2006 (F2006L03473)

3 Nov 2006

277, 2006

2 Nov 2006 (F2006L03474)

3 Nov 2006

278, 2006

2 Nov 2006 (F2006L03475)

3 Nov 2006

279, 2006

2 Nov 2006 (F2006L03476)

3 Nov 2006

280, 2006

2 Nov 2006 (F2006L03538)

3 Nov 2006

3, 2007

16 Feb 2007 (F2007L00284)

17 Feb 2007

39, 2007

23 Mar 2007 (F2007L00577)

24 Mar 2007

47, 2007

30 Mar 2007 (F2007L00847)

31 Mar 2007

48, 2007

30 Mar 2007 (F2007L00850)

31 Mar 2007

49, 2007

30 Mar 2007 (F2007L00713)

31 Mar 2007

50, 2007

30 Mar 2007 (F2007L00851)

31 Mar 2007

51, 2007

30 Mar 2007 (F2007L00848)

31 Mar 2007

52, 2007

30 Mar 2007 (F2007L00712)

31 Mar 2007

125, 2007

24 May 2007 (F2007L01465)

25 May 2007

265, 2007

7 Sept 2007 (F2007L03535)

8 Sept 2007

266, 2007

7 Sept 2007 (F2007L03537)

8 Sept 2007

267, 2007

7 Sept 2007 (F2007L03536)

8 Sept 2007

290, 2007

27 Sept 2007 (F2007L03752)

28 Sept 2007

160, 2008

8 Aug 2008 (F2008L02843)

9 Aug 2008

161, 2008

8 Aug 2008 (F2008L02845)

9 Aug 2008

162, 2008

8 Aug 2008 (F2008L02844)

9 Aug 2008

218, 2008

31 Oct 2008 (F2008L03611)

1 Nov 2008

219, 2008

31 Oct 2008 (F2008L03612)

1 Nov 2008

220, 2008

31 Oct 2008 (F2008L03610)

1 Nov 2008

34, 2009

13 Mar 2009 (F2009L00835)

14 Mar 2009

35, 2009

13 Mar 2009 (F2009L00834)

14 Mar 2009

36, 2009

13 Mar 2009 (F2009L00838)

14 Mar 2009

37, 2009

13 Mar 2009 (F2009L00837)

14 Mar 2009

38, 2009

13 Mar 2009 (F2009L00836)

14 Mar 2009

39, 2009

13 Mar 2009 (F2009L00833)

14 Mar 2009

77, 2009

15 May 2009 (F2009L01297)

16 May 2009

124, 2009

25 June 2009 (F2009L02476)

never commenced
(SLI No 176, 2009)

125, 2009

25 June 2009 (F2009L02471)

never commenced
(SLI No 176, 2009)

126, 2009

25 June 2009 (F2009L02477)

never commenced
(SLI No 176, 2009)

127, 2009

25 June 2009 (F2009L02478)

never commenced
(SLI No 176, 2009)

208, 2009

21 Aug 2009 (F2009L03208)

22 Aug 2009

212, 2009

7 Sept 2009 (F2009L03396)

8 Sept 2009

213, 2009

7 Sept 2009 (F2009L03397)

8 Sept 2009

214, 2009

7 Sept 2009 (F2009L03398)

8 Sept 2009

215, 2009

7 Sept 2009 (F2009L03399)

8 Sept 2009

219, 2010

21 July 2010 (F2010L02093)

22 July 2010

220, 2010

21 July 2010 (F2010L02094)

22 July 2010

221, 2010

21 July 2010 (F2010L02095)

22 July 2010

222, 2010

21 July 2010 (F2010L02096)

27 Nov 2010 (r 2)

252, 2010

28 Oct 2010 (F2010L02825)

29 Oct 2010

253, 2010

28 Oct 2010 (F2010L02826)

29 Oct 2010

254, 2010

28 Oct 2010 (F2010L02828)

29 Oct 2010

45, 2011

8 Apr 2011 (F2011L00586)

9 Apr 2011

22, 2012

9 Mar 2012 (F2012L00553)

10 Mar 2012

23, 2012

9 Mar 2012 (F2012L00554)

10 Mar 2012

24, 2012

9 Mar 2012 (F2012L00555)

10 Mar 2012

25, 2012

9 Mar 2012 (F2012L00556)

10 Mar 2012

40, 2012

5 Apr 2012 (F2012L00796)

9 Apr 2012

59, 2012

11 May 2012 (F2012L01016)

12 May 2012

191, 2012

17 Aug 2012 (F2012L01693)

18 Aug 2012

192, 2012

17 Aug 2012 (F2012L01694)

18 Aug 2012

193, 2012

17 Aug 2012 (F2012L01695)

18 Aug 2012

194, 2012

17 Aug 2012 (F2012L01696)

18 Aug 2012

195, 2012

17 Aug 2012 (F2012L01697)

18 Aug 2012

66, 2013

23 May 2013 (F2013L00825)

28 May 2013 (s 2)

160, 2013

11 July 2013 (F2013L01353)

12 July 2013 (s 2)

161, 2013

11 July 2013 (F2013L01357)

12 July 2013 (s 2)

162, 2013

11 July 2013 (F2013L01358)

12 July 2013 (s 2)

163, 2013

11 July 2013 (F2013L01354)

12 July 2013 (s 2)

164, 2013

11 July 2013 (F2013L01356)

12 July 2013 (s 2)

165, 2013

11 July 2013 (F2013L01355)

12 July 2013 (s 2)

241, 2013

25 Nov 2013 (F2013L01969)

26 Nov 2013 (s 2)

47, 2014

16 May 2014 (F2014L00550)

17 May 2014 (s 2)

117, 2014

5 Aug 2014 (F2014L01073)

6 Aug 2014 (s 2)

6, 2015

2 Mar 2015 (F2015L00234)

3 Mar 2015 (s 2)

7, 2015

2 Mar 2015 (F2015L00235)

3 Mar 2015 (s 2)

8, 2015

2 Mar 2015 (F2015L00233)

3 Mar 2015 (s 2)

9, 2015

2 Mar 2015 (F2015L00236)

3 Mar 2015 (s 2)

57, 2015

1 May 2015 (F2015L00621)

2 May 2015 (s 2)

126, 2015

10 Aug 2015 (F2015L01237)

11 Aug 2015 (s 2(1) item 1)

127, 2015

10 Aug 2015 (F2015L01238)

11 Aug 2015 (s 2(1) item 1)

128, 2015

10 Aug 2015 (F2015L01236)

11 Aug 2015 (s 2(1) item 1)

129, 2015

10 Aug 2015 (F2015L01235)

11 Aug 2015 (s 2(1) item 1)

130, 2015

10 Aug 2015 (F2015L01239)

11 Aug 2015 (s 2(1) item 1)

250, 2015

14 Dec 2015 (F2015L01993)

15 Dec 2015 (s 2(1) item 1)

 

Name

Registration

Commencement

Application, saving and transitional provisions

Criminal Code Amendment (Control Orders—Legal Representation for Young People) Regulations 2017

30 June 2017 (F2017L00843)

1 July 2017 (s 2(1) item 1)

Criminal Code Amendment (High Risk Terrorist Offenders) Regulations 2017

17 Nov 2017 (F2017L01490)

18 Nov 2017 (s 2(1) item 1)

 

Endnote 4—Amendment history

 

Provision affected

How affected

Part 1

 

Part 1 heading..................................

ad No 248, 2002

r 2...................................................

rep LA s 48D

r 3...................................................

am No 265, 2007; No 250, 2015; F2017L00843

Part 2

 

Part 2...............................................

ad No 248, 2002

Division 1

 

Division 1.......................................

ad F2017L00843

r 3A.................................................

ad F2017L00843

r 3B.................................................

ad F2017L00843

r 3C.................................................

ad F2017L00843

Division 2

 

Division 2 heading..........................

ad F2017L00843

r 4...................................................

ad No 248, 2002

 

rs No 184, 2003

 

am No 285, 2003; No 85, 2005; No 86, 2005; No 87, 2005; No 88, 2005

 

rep No 298, 2005

 

ad No 178, 2006

 

am No 280, 2006

r 4A.................................................

ad No 283, 2004

 

rs No 220, 2006; No 160, 2008; No 219, 2010

 

rep No 161, 2013

 

ad F2017L01490

r 4B.................................................

ad No 284, 2004

 

rs No 221, 2006; No 161, 2008; No 220, 2010

 

rep No 165, 2013

 

ad F2017L01490

r 4C.................................................

ad No 311, 2004

 

rs No 276, 2006; No 218, 2008; No 253, 2010

 

rep No 160, 2013

r 4D.................................................

ad No 312, 2004

 

rs No 277, 2006; No 220, 2008; No 252, 2010

 

rep No 164, 2013

r 4E.................................................

ad No 313, 2004

 

rs No 278, 2006

 

rep No 191, 2012

r 4F.................................................

ad No 314, 2004

 

rs No 279, 2006; No 162, 2008; No 221, 2010

 

rep No 163, 2013

r 4G.................................................

ad No 23, 2005

 

rs No 3, 2007; No 219, 2008; No 254, 2010

 

rep No 162, 2013

r 4H.................................................

ad No 36, 2005

 

rs No 39, 2007; No 34, 2009; No 22, 2012

 

rep No 6, 2015

r 4I..................................................

ad No 60, 2005

 

rs No 47, 2007; No 35, 2009

 

rep No 191, 2012

r 4J..................................................

ad No 58, 2005

 

rs No 48, 2007; No 39, 2009; No 23, 2012

 

rep No 7, 2015

r 4K.................................................

ad No 57, 2005

 

rs No 52, 2007; No 36, 2009; No 24, 2012

 

rep No 8, 2015

r 4L.................................................

ad No 61, 2005

 

rs No 49, 2007; No 38, 2009; No 25, 2012

 

rep No 9, 2015

r 4M................................................

ad No 59, 2005

 

rs No 50, 2007

 

rep No 191, 2012

r 4N.................................................

ad No 62, 2005

 

rs No 51, 2007; No 37, 2009

 

rep No 191, 2012

r 4P.................................................

ad No 88, 2005

 

rep No 214, 2005

r 4Q.................................................

ad No 85, 2005

 

rs No 125, 2007; No 77, 2009; No 59, 2012

 

rep No 57, 2015

r 4R.................................................

ad No 86, 2005

 

rep No 214, 2005

r 4S.................................................

ad No 87, 2005

 

rep No 214, 2005

r 4T.................................................

ad No 214, 2005

 

rs No 265, 2007; No 212, 2009; No 194, 2012

 

rep No 130, 2015

r 4U.................................................

adNo 214, 2005

 

rs No 266, 2007; No 213, 2009; No 191, 2012

 

rep No 128, 2015

r 4V.................................................

ad No 214, 2005

 

rs No 267, 2007; No 214, 2009; 2012 No 192, 2012

 

rep No 127, 2015

r 4W................................................

ad No 298, 2005

 

rs No 290, 2007; No 215, 2009; No 195, 2012

rep No 126, 2015

r 4X.................................................

ad No 208, 2009

 

rs No 193, 2012

 

rep No 129, 2015

r 4Y.................................................

ad No 222, 2010

 

rep No 241, 2013

Part 3

 

Part 3 heading..................................

rs No 66, 2013

Division 3.1 heading.......................

ad No 66, 2013

 

rs and renum F2017L00843

Division 1

 

Division 1 heading (prev Division 3.1
heading)

 

Part 3...............................................

ad No 30, 2003

r 5AA..............................................

ad No 45, 2011

 

rep No 40, 2012

r 5AB..............................................

ad No 45, 2011

 

rep No 40, 2012

r 5AC..............................................

ad No 45, 2011

 

rep No 40, 2012

r 5...................................................

ad No 30, 2003

Division 3.2....................................

ad No 66, 2013

Division 3.2 heading.......................

rs and renum F2017L00843

Division 2

 

Division 2 heading (prev Division 3.2
heading)

 

r. 5A................................................

ad No 66, 2013

r. 5B................................................

ad No 66, 2013

r. 5C................................................

ad No 66, 2013

r. 5D................................................

ad No 66, 2013

r. 5E................................................

ad No 66, 2013

r. 5F................................................

ad No 66, 2013

Division 3.3....................................

ad No 250, 2015

Division 3.3 heading.......................

rs and renum F2017L00843

Division 3

 

Division 3 heading (prev Division 3.3
heading)

 

r 5G.................................................

ad No 250, 2015

r 5H.................................................

ad No 250, 2015

Part 4

 

Part 3 heading..................................

ad No 248, 2002

Part 4 heading (prev Part 3).............

renum No 30, 2003

r 5 (prev r 4)...................................

renum No 248,2002

r 6 (prev r 5)...................................

renum No 30, 2008

Part 5

 

Part 5...............................................

ad F2017L00843

r 7...................................................

ad F2017L00843

Schedule 1

 

Schedule 1.......................................

ad 2002 No 248

 

am No 249, 2002; No 250, 2002; No 269, 2002; No 270, 2002; No 271, 2002; No 272, 2002; No 43, 2003; No 59, 2003; No 60, 2003; No 61, 2003; No 62, 2003; No 63, 2003; No 64, 2003; No 83, 2004; No 283, 2004; No 284, 2004; No 311, 2004; No 312, 2004; No 313, 2004; No 314, 2004; No 36, 2005; No 57, 2005; No 58, 2005; No 59, 2005; No 60, 2005; No 61, 2005; No 62, 2005

 

rep No 88, 2005

 

ad No 178, 2006

 

am No 280, 2006

Schedule 1A heading.......................

rs No 285, 2003

 

rep No 298, 2005

 

ad No 45, 2011

 

rep No 40, 2012

Schedule 1A....................................

ad No 184, 2003

 

rep No 298, 2005

 

ad No 45, 2011

 

rep No 40, 2012

Part 1 heading..................................

ad No 285, 2003

 

rep No 85, 2005

 

ad No 45, 2011

 

rep No 40, 2012

Part 1...............................................

rep No 85, 2005

 

ad No 45, 2011

 

rep No 40, 2012

Part 2...............................................

ad No 285, 2003

 

rep No 86, 2005

 

ad No 45, 2011

 

rep No 40, 2012

Part 3...............................................

ad No 285, 2003

 

rep No 87, 2005

 

ad No 45, 2011

 

rep No 40, 2012

Part 4...............................................

ad No 45, 2011

 

rep No 40, 2012

Schedule 2

 

Schedule 2.......................................

ad No 30, 2003

Schedule 3

 

Schedule 3.......................................

ad No 66, 2013

 

am No 62, 2014

Schedule 4

 

Schedule 4.......................................

ad No 66, 2013

 

am No 47, 2014